Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation
Close
Home
Company
About
Leadership
Careers
Pipeline
Development Pipeline
Targeted Therapeutics
Systemic Therapeutics
Publications
Investors
Investor Overview
Press Releases
Events & Presentations
SEC Filings
Annual & Quarterly Reports
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Governance Documents
Committee Composition
Investor FAQs
Investor Email Alerts
Investor Relations Contact
Contact
Toggle the search bar
Search the Site
Close the mobile navigation
Publications
Select Category
Select Category...
Gastrointestinal Health
Systemic Therapeutics
Targeted Therapeutics
Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
October 23, 2022
#Systemic Therapeutics
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
October 23, 2022
#Systemic Therapeutics
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
October 18, 2022
#Systemic Therapeutics
Connect with us
Email Us
Biora Therapeutics Linkedin
Biora Therapeutics Twitter